Funder
the National Key Research and Development Program of China
National Natural Science Foundation of China
Shanghai Science and Technology Project
Shanghai Municipal Key Clinical Specialty
JianFeng project of XuHui Provincial Commission of Health and Family Planning
the Clinical Study of Zhongshan Hospital
the Shanghai Sailing Program
the Youth Foundation of Zhongshan Hospital
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference37 articles.
1. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. (2015) Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford). 17(8):691–699.
2. Ito F, Cho C S, Rikkers L F, et al. (2009) Hilar cholangiocarcinoma: current management. Annals of surgery.250(2): 210–218.
3. Inoue K, MakuuchiM, Takayama T, et al. (2000) Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 127:498-505.
4. Keidar Z, Haim N, Guralnik L, et al. (2004) PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med. 45:1640-1646.
5. Votrubova J, Belohlavek O, Jaruskova M, et al. (2006) The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging. 33:779-784.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献